The importance of accessory signaling pathways amplifying endotoxin responses has recently been highlighted by genetic studies describing LPS-hyporesponsive individuals despite carrying the common allele for TLR4. The nucleotide receptor P2X 7 modulates the production of numerous LPS-stimulated inflammatory mediators. We have recently described the largest phenotypic screen known for genetic polymorphisms associated with the nucleotide receptor P2X 7 , a global regulator of leukocyte function. This required the development of a novel monocyte pore assay with numerous advantages over previous methods and with the potential to facilitate rapid (< 3 h), multiplex analysis of clinical samples. This paper addresses aspects pertinent to the development of the monocyte pore assay, briefly summarizes our results suggesting that P2X 7 alleles modulate LPSstimulated cytokine production, and discusses a model wherein P2X 7 may serve as an amplification loop of innate immunity.
INTRODUCTION
Genetic factors controlling the variability in the responsiveness of the innate immune system were first suggested in a landmark adoption study by Sørensen et al. 1 wherein the premature death of biological parents and their children raised in adopted homes was most strongly linked to death from infectious causes. More recent work has documented increased relative risks for the incidence or severe progression of a major infection associated with the inheritance of polymorphisms of several candidate genes encoding components of the lipopolysaccharide (LPS) receptor signaling system or downstream inflammatory mediators. [2] [3] [4] [5] [6] In addition to CD14/TLR4, accessory LPS-signaling pathways are well-recognized and genetic variability at these and other loci may account for LPS-hyporesponsive individuals carrying the common alleles for traditional LPS receptors. Discovery of these accessory pathways may be greatly facilitated by functional assays that account for the influence of numerous alleles, screen for new polymorphisms and/or genetic loci, and can be directly linked to surrogate endpoints that have biological relevance in the pathogenesis of LPS-induced diseases.
The nucleotide receptor P2X 7 is a cation channel and reversible pore that is expressed in most classes of leukocytes, modulating numerous LPS-stimulated signaling events and inflammatory mediators via stimulation by endogenous nucleotides released by platelets and apoptotic cells at sites of inflammation. 7 Several polymorphisms exist for the human P2X 7 gene, only two of which have been associated with a clinical disease affecting the immune system. 8, 9 We therefore sought to develop a rapid functional assay in whole blood in order to better define the clinical significance of these alleles with respect to immune response variability in the setting of infection or inflammation. The results described herein suggest that monocyte pore activity can be rapidly measured in whole blood and is a stable phenotype.
MATERIALS AND METHODS

Human subject participation
This study was in accordance with the principles of the Declaration of Helsinki, and was prospectively approved by the UW Institutional Review Board. Furthermore, all participating subjects verified their informed consent in writing. Further description of these healthy adult subjects has been reported. 10 
Determination of the P2X 7 A1513C and T1729A genotypes
Genomic DNA was prepared from frozen whole blood samples using the Puregene DNA Isolation kit (Gentra Systems, Minneapolis, MN, USA). Genotypes were determined by PCR-based restriction fragment length polymorphism analysis and sequencing, as described. 10 Fig. 1 . Derivation of instrument settings for the washed whole blood pore assay. (A) Demonstrates the inability to discriminate monocytes by size (forward scatter) and granularity (side scatter) in the presence of an overwhelming number of RBCs and platelets. Mononuclear cells derived after one round of RBC lysis (B) display the characteristic scatter associated with granulocytes, monocytes and lymphocytes. The circle, or gate, denotes the approximate position assumed by monocytes. The shading in (A,B) is reflective of increasing cell number, dark to light. Gated cells are shown in (C) to express CD14, a monocyte marker. Baseline YO-PRO-1 fluorescence associated with CD14 + monocytes is then set as low as possible (D) to maximize the potential fold increase in the Bz-ATP induced signal.
Rapid measurement of monocyte P2X 7 pore activity by flow cytometry of washed whole blood Aliquots of citrated whole blood (500 ml/aliquot) were washed twice in HEPES-buffered saline (HBS: 130 mM NaCl, 5 mM KCl, 20 mM HEPES pH 7.4, 0.1% bovine serum albumin, 10 mM glucose; components purchased at Sigma, St Louis, MO, USA) and then labeled at room temperature with 125 ng of an anti-human CD14 antibody conjugated to phycoerythrin (BD Biosciences, San Diego, CA, USA). After 20 min, the cells were washed twice in a potassium glutamate buffer (130 mM potassium glutamate, 5 mM KCl, 20 mM HEPES pH 7.4, 0.1% bovine serum albumin, 10 mM glucose; components from Sigma) to maximize the differences between high and low pore activities. 11 In the absence of NaCl, cells were stimulated for 20 min with 0 or 250 mM 2¢-3¢-O-(4-benzoylbenzoyl) adenosine 5¢-triphosphate (Bz-ATP; Sigma) in the presence of 1 mM YO-PRO-1 (Molecular Probes, Eugene, OR, USA). Samples were then adjusted to 10 mM magnesium chloride, washed in HEPES-buffered saline and diluted to a volume of 2.5 ml in HBS.
Flow cytometry was performed on a FACScan flow cytometer (Becton Dickinson, San Jose, CA, USA) that was calibrated daily using standard fluorimetric beads. The instrument settings were derived prior to enrolling study subjects using purified blood monocytes that had been separated from the red cells with Ficoll-Hypaque (Sigma), and stained with a phycoerythrin-conjugated anti-CD14 antibody in the presence and absence of YO-PRO-1. The phycoerythrin signal was collected with a 585 nm filter with a 42 nm band pass, whereas the YO-PRO-1 signal was collected with a 530 nm filter and a 30 nm band pass. Using the results from the purified monocytes, the instrument was then set to trigger on the phycoerythrin signal by setting the threshold above the background associated from unlabeled cells. Thus, data from all non-phycoerythrin labeled cells were not acquired. Because the YO-PRO-1 signal is so intense, channel compensation (~30%) was used to eliminate the YO-PRO-1 signal in the phycoerythrin channel.
For each experiment with washed whole blood from the study subjects, the standard instrument settings were called up from a stored file and used without adjustment. Ten thousand phycoerythrin-labeled events were acquired using CellQuest and CellQuestPro acquisition and analysis software (v. 3.3 and 4.0; Becton Dickinson) and the amount of YO-PRO-1 taken up by these cells was measured in the presence or absence of prior stimulation with the P2X 7 agonist, Bz-ATP. Data analysis was done as a batch using FlowJo software (v. 4.3; Tree Star, Inc., Palo Alto, CA, USA) in order to apply the same CD14 + gates to the entire study. The fold stimulation of P2X 7 pore activity was calculated using the ratio of the geometric mean of YO-PRO-1 fluorescence associated with the Bz-ATP-treated sample relative to that derived from the control.
RESULTS AND DISCUSSION
Development of a rapid phenotypic screen for individuals with P2X 7 genetic polymorphisms
Previous methods used to study the P2X 7 pore activity in primary cells include the lysis of erythrocytes, the isolation of whole blood leukocytes by gradient centrifugation or the purification of lymph node T cells. 8, 12 Because we were interested in identifying individuals with novel P2X 7 genetic polymorphisms, we developed an assay that is more amenable to larger screens, potentially with greater sensitivity for detecting alleles with subtle influence on leukocyte P2X 7 pore activity. As shown in Figure 1A ,B, the ability to detect specific populations of leukocytes according to their size and granularity was lost in the context of whole blood due to noise created by an overwhelming number of erythrocytes and platelets. However, labeling these cells with a CD14-specific antibody allowed for the use of a threshold technique to rapidly identify monocytes in whole blood samples (Fig. 1C,D) . By choosing conditions that amplify pore activity, this whole blood assay produced large differences between the monocyte pore activity in samples A novel assay to detect nucleotide receptor P2X 7 genetic polymorphisms 139 from individuals with the P2X 7 1513 CC genotype relative to those from subjects with the AC or AA genotypes (Fig. 2) . Specifically, treatment of washed whole blood for 20 min with the potent P2X 7 agonist Bz-ATP in an isotonic buffer solution lacking sodium chloride allowed for the passage of the fluorescent dye YO-PRO-1 (Fig.  2) . This assay produced a stable phenotype in that the range of day-to-day variability from 41 subjects averaged at 31 ± 22% of the individual subject's mean.
Potential influence of P2X 7 alleles and pore activity on leukocyte function
We have recently demonstrated that 30 of 200 (15%) healthy adults carry P2X 7 or other alleles that attenuate monocyte pore activity. 10 When whole blood samples were stimulated with LPS from Salmonella typhimurium, the individuals with low monocyte P2X 7 pore activity had lower plasma levels of TNF-a and higher amounts of interleukin-10 (IL-10). 10 Because P2X 7 regulates numerous signaling endpoints including calcium influx, activation of caspase-1, matrix metalloproteases, and several mitogen-activatable protein kinases, and the nuclear mobilization of transcription factors such as NF-kB, NFAT, and AP-1, this receptor has the potential to modulate a variety of leukocyte functions (reviewed in Denlinger et al. 10 ; functions listed in Table 1 ). Additionally, P2X 7 alleles have recently been linked to a variety of immune functions ( Table 2) . Although other models are conceivable, 10 the cell surface localization of the alanine-496 variant P2X 7 8 suggests that there are channel-and pore-independent P2X 7 signaling mechanisms 13 that contribute to LPS-induced IL-10 generation when its pore function is attenuated. With respect to macrophage heterogeneity, this raises the possibility that the relative degree of P2X 7 functionality in part determines the pathway (classical versus type II) of macrophage activation. 14 
CONCLUSIONS
We have developed a rapid, washed whole-blood pore assay that has numerous advantages over previous methods for detecting P2X 7 , and possibly other, allele variants influencing pore activity. In particular, the antibody labeling and flow cytometric threshold techniques allow for the functional assessment of monocytes (or other cell types) using £ 1 ml of whole blood, an aspect that has tremendous significance regarding the potential for future use in an unstable, critically-ill patient population. Moreover, the technique is readily adaptable for use in a clinical laboratory of an average community hospital, broadening its applicability compared to previous methods. Because the results are available in less than 3 h from the time of phlebotomy, the design of immunomodulatory clinical trials with prospective stratification of patient subsets is now possible. An underlying hypothesis for these trials would be that septic patients with attenuated monocyte P2X 7 pore activity would be relatively protected from 140 Denlinger, Schell, Angelini et al. organ dysfunction and shock, potentially at the expense of a diminished ability to control the infection locally or at increased susceptibility to certain classes (e.g. intracellular) of microbial pathogens. Decreased incidence of smear positive tuberculosis 9 1513 C, 1729 A, and others associated with low monocyte P2X 7 pore activity Decreased TNF-a to IL-10 ratio in response to whole blood stimulation with LPS 10
